Results 91 to 100 of about 16,261 (182)
Pityriasis Versicolor-A Narrative Review on the Diagnosis and Management. [PDF]
Łabędź N +5 more
europepmc +1 more source
Pityriasis versicolor adalah infeksi jamur yang sering dijumpai didaerah tropis. Angka kejadian di Indonesia yang mencapai 40% berdasar laporan beberapa rumah sakit.
Lalchanzani, Jawaharlal Akbar +2 more
core
The lipophilic yeasts of Malassezia species are members of the normal skin microbial that are cause of pityriasis versicolor. Pityriasis versicolor is a common superficial fungal infection with world-wide distribution.
Mojtaba Didehdar +6 more
doaj
COMPARISON OF ORAL ITRACONAZOLE VERSUS TOPICAL CLOTRIMAZOLE IN TREATMENT OF PITYRIASIS VERSICOLOR
Objective: To compare the efficacy of single dose of oral itraconazole 400mg with 1% topical clotrimazole in the treatment of pityriasis versicolor. Study Design: Randomized controlled trial. Place and Duration of Study: Dermatology department, Military
Sameena Kausar +3 more
doaj +2 more sources
Pityriasis Versicolor Tropicalis [PDF]
openaire +2 more sources
Pityriasis versicolor on the scalp: An unusual distribution of a common disease. [PDF]
Wang L, Xing H.
europepmc +1 more source
Background: Malassezia species are lipophilic yeasts found on the skin surface of humans and other warm-blooded vertebrates. It is associated with various human diseases, especially pityriasis versicolor, which is a chronic superficial skin disorder ...
Erami, M. +5 more
core
Clinico-Mycological Study Of Superficial Fungal Infection In Children In An Urban Clinic In Kolkata
Seventy children up to the age of 12 years who were suffering from dermatophytosis, candidiasis or pityriasis versicolor were studied clinically and mycologically. Dermatophytosis was the major group, which constituted 52.86% of children.
Barbhuiya Joyashree Nath +4 more
doaj
"PiMa sign": A possible correlation between dermographism and pityriasis versicolor? [PDF]
Martora F +3 more
europepmc +1 more source
Pityriasis Versicolor Resistant to Antifungal Drugs in a Patient in Lomé (Togo). [PDF]
Teclessou J +4 more
europepmc +1 more source

